Publication | Open Access

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

InflammationHematological MalignancyMedicineCell AdhesionImmunologyAdhesion MoleculesImmunomodulatory DrugsImmunotherapyPharmacologyRankl/opg RatioTumor Microenvironment